
Nate Edwards of Arya Consulting, Elisabeth Gardiner of Tevard Biosciences, and Donny Xu of the RTW Institute discuss global competition for rare disease therapies.
Steer small.
almost 22 years ago
February 2005almost 22 years ago
Good Work and True: USP Prepares for Convention 2005almost 22 years ago
Contract Manufacturers Getting Squeezedalmost 22 years ago
In the Spotlight-February 2005almost 22 years ago
Emerging Analytical Technology: Moving from the Lab to the Linealmost 22 years ago
Drug Safety Fears May Limit Reimporting and Shape R&Dalmost 22 years ago
In Defense of USP Singlet Testing





